Silodosin Recordati
- Prescription status not stated
- Urinary and reproductive system, hormones
- Active substance
- Silodosin
- Made by
- Recordati Ireland Ltd
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) in adult men.
From the official label · 2026-09-30 · European Medicines Agency
How it works
From the US prescribing label for the same active substance (SILODOSIN). It describes the substance, not this exact product.
Silodosin is a selective antagonist of post-synaptic alpha-1 adrenoreceptors, which are located in the human prostate, bladder base, bladder neck, prostatic capsule, and prostatic urethra.
Blockade of these alpha-1 adrenoreceptors can cause smooth muscle in these tissues to relax, resulting in an improvement in urine flow and a reduction in BPH symptoms.
Silodosin undergoes extensive metabolism through glucuronidation, alcohol and aldehyde dehydrogenase, and cytochrome P450 3A4 (CYP3A4) pathways.
Food Effect The maximum effect of food (i.e., co-administration with a high fat, high calorie meal) on the PK of silodosin was not evaluated.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-08-18
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Recordati Ireland Ltd |
|---|---|
| Active substance | Silodosin |
| Used in | Urinary and reproductive system, hormones |
| Classification | G04CA04 · Urinary and reproductive system, hormones |
| Generic | Yes — a generic medicine, according to the register |
| Authorised on | 2019-01-07 |
| Last updated by the regulator | 2025-03-10 |
| EMA product number | EMEA/H/C/004964 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.